These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35927462)

  • 41. American Academy of Pediatrics' Updated Clinical Guidelines for Managing Neonatal Hyperbilirubinemia.
    Beal JA
    MCN Am J Matern Child Nurs; 2023 Jan-Feb 01; 48(1):49. PubMed ID: 36469895
    [No Abstract]   [Full Text] [Related]  

  • 42. Hyperbilirubinemia in newborns with gestation ≥35 weeks.
    Sankaran K
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Oct; 12(10):761-6. PubMed ID: 20959036
    [No Abstract]   [Full Text] [Related]  

  • 43. Neonatal hyperbilirubinemia management: Clinical assessment of bilirubin production.
    Du L; Ma X; Shen X; Bao Y; Chen L; Bhutani VK
    Semin Perinatol; 2021 Feb; 45(1):151351. PubMed ID: 33308896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neonatal Hyperbilirubinemia: An Updated Appraisal of National Guidelines.
    Capasso L; Palma M; Coppola C; Salomè S; Esposito V; Grappone L; Raimondi F
    Curr Pediatr Rev; 2020; 16(4):298-306. PubMed ID: 32988353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcutaneous bilirubin in predicting hyperbilirubinemia in term neonates.
    Bhat YR; Rao A
    Indian J Pediatr; 2008 Feb; 75(2):119-23. PubMed ID: 18334790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new hour-specific serum bilirubin nomogram for neonates ≥35 weeks of gestation.
    Maisels MJ; Newman TB; Kaplan M
    J Pediatr; 2021 Oct; 237():317. PubMed ID: 34265340
    [No Abstract]   [Full Text] [Related]  

  • 47. Exchange transfusion for hemolytic hyperbilirubinemia: could some be averted by emergent administration of an inhibitor of bilirubin production?
    Wiedmeier SE; Bahr TM; Ohls RK; Christensen TR; Baer VL; Ilstrup SJ; Cail K; Christensen RD
    J Perinatol; 2021 Apr; 41(4):860-864. PubMed ID: 32669646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neonatal Hyperbilirubinemia in a Marginalized Population on the Thai-Myanmar Border: a study protocol.
    Thielemans L; Trip-Hoving M; Bancone G; Turner C; Simpson JA; Hanboonkunupakarn B; van Hensbroek MB; van Rheenen P; Paw MK; Nosten F; McGready R; Carrara VI
    BMC Pediatr; 2017 Jan; 17(1):32. PubMed ID: 28109243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperbilirubinemia: current guidelines and emerging therapies.
    Schwartz HP; Haberman BE; Ruddy RM
    Pediatr Emerg Care; 2011 Sep; 27(9):884-9. PubMed ID: 21926893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperbilirubinemia and kernicterus.
    Shapiro SM; Bhutani VK; Johnson L
    Clin Perinatol; 2006 Jun; 33(2):387-410. PubMed ID: 16765731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Severe Neonatal Hyperbilirubinemia Decreased after the 2007 Canadian Guidelines.
    Sgro M; Kandasamy S; Shah V; Ofner M; Campbell D
    J Pediatr; 2016 Apr; 171():43-7. PubMed ID: 26852177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uniform treatment thresholds for hyperbilirubinemia in preterm infants: background and synopsis of a national guideline.
    van Imhoff DE; Dijk PH; Hulzebos CV;
    Early Hum Dev; 2011 Aug; 87(8):521-5. PubMed ID: 21621933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of the need for phototherapy during hospital stay in preterm infants by transcutaneous bilirubinometry.
    Raba AA; O'Sullivan A; Miletin J
    Early Hum Dev; 2020 Jul; 146():105029. PubMed ID: 32442814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predischarge non-invasive risk assessment for prediction of significant hyperbilirubinemia in term and late preterm neonates.
    Kaur S; Chawla D; Pathak U; Jain S
    J Perinatol; 2012 Sep; 32(9):716-21. PubMed ID: 22094493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants.
    Keren R; Luan X; Friedman S; Saddlemire S; Cnaan A; Bhutani VK
    Pediatrics; 2008 Jan; 121(1):e170-9. PubMed ID: 18166536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A rare cause of neonatal persistent jaundice.
    Oliveira GN; Dinis I; Noruegas MJ; Mirante A
    BMJ Case Rep; 2017 Dec; 2017():. PubMed ID: 29275395
    [No Abstract]   [Full Text] [Related]  

  • 57. Effectiveness of universal hyperbilirubinemia screening on newborn health: a systematic review protocol.
    Khurshid F; Medves J
    JBI Database System Rev Implement Rep; 2018 Feb; 16(2):287-290. PubMed ID: 29419612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Head off complications in late preterm infants.
    Stuckey-Schrock K; Schrock SD
    J Fam Pract; 2013 Apr; 62(4):E3-8. PubMed ID: 23570036
    [No Abstract]   [Full Text] [Related]  

  • 59. [Management of hyperbilirubinemia in the newborn infant at 38 or more weeks of gestation].
    Colombo M; Sassi G; Contratti M; Corna A; Sicchiero C; Volpini S; Fazi C; Tedoldi S; Bresciani E; Ciceri A
    Minerva Pediatr; 2006 Aug; 58(4):399-400. PubMed ID: 17008851
    [No Abstract]   [Full Text] [Related]  

  • 60. Current Scope of Practice for Newborn Care in Non-Intensive Hospital Settings.
    Chung EK; Gable EK; Golden WC; Hudson JA; Hackman NM; Andrews JP; Jackson DS; Beavers JB; Mirchandani DR; Kellams A; Krevitsky ME; Monroe K; Madlon-Kay DJ; Stratbucker W; Campbell D; Collins J; Rauch D
    Hosp Pediatr; 2017 Aug; 7(8):471-482. PubMed ID: 28694290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.